HealthEquity (HQY) Revenue & Revenue Breakdown
HealthEquity Revenue Highlights
Latest Revenue (Y)
$1.20B
Latest Revenue (Q)
$325.83M
Main Segment (Y)
Financial Service, Other
HealthEquity Revenue by Period
HealthEquity Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-01-31 | $1.20B | 20.03% |
| 2024-01-31 | $999.59M | 16.00% |
| 2023-01-31 | $861.75M | 13.90% |
| 2022-01-31 | $756.56M | 3.13% |
| 2021-01-31 | $733.57M | 37.89% |
| 2020-01-31 | $531.99M | 85.21% |
| 2019-01-31 | $287.24M | 25.15% |
| 2018-01-31 | $229.53M | 28.68% |
| 2017-01-31 | $178.37M | 40.69% |
| 2016-01-31 | $126.79M | 44.31% |
| 2015-01-31 | $87.86M | 41.67% |
| 2014-01-31 | $62.02M | 34.56% |
| 2013-01-31 | $46.09M | - |
HealthEquity generated $1.20B in revenue during NA 2025, up 20.03% compared to the previous quarter, and up 225.52% compared to the same period a year ago.
HealthEquity Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-07-31 | $325.83M | -1.51% |
| 2025-04-30 | $330.84M | 6.10% |
| 2025-01-31 | $311.82M | 3.79% |
| 2024-10-31 | $300.43M | 0.17% |
| 2024-07-31 | $299.93M | 4.29% |
| 2024-04-30 | $287.60M | 9.61% |
| 2024-01-31 | $262.39M | 5.28% |
| 2023-10-31 | $249.22M | 2.33% |
| 2023-07-31 | $243.55M | -0.36% |
| 2023-04-30 | $244.43M | 4.53% |
| 2023-01-31 | $233.84M | 8.22% |
| 2022-10-31 | $216.09M | 4.82% |
| 2022-07-31 | $206.14M | 0.23% |
| 2022-04-30 | $205.68M | 1.17% |
| 2022-01-31 | $203.30M | 12.97% |
| 2021-10-31 | $179.95M | -4.84% |
| 2021-07-31 | $189.10M | 2.66% |
| 2021-04-30 | $184.20M | -2.11% |
| 2021-01-31 | $188.17M | 4.92% |
| 2020-10-31 | $179.35M | 1.88% |
| 2020-07-31 | $176.04M | -7.35% |
| 2020-04-30 | $190.01M | -5.56% |
| 2020-01-31 | $201.20M | 28.06% |
| 2019-10-31 | $157.12M | 81.38% |
| 2019-07-31 | $86.62M | -0.49% |
| 2019-04-30 | $87.05M | 14.88% |
| 2019-01-31 | $75.78M | 7.49% |
| 2018-10-31 | $70.50M | -0.80% |
| 2018-07-31 | $71.07M | 1.66% |
| 2018-04-30 | $69.90M | 15.67% |
| 2018-01-31 | $60.44M | 6.42% |
| 2017-10-31 | $56.79M | -0.16% |
| 2017-07-31 | $56.88M | 2.63% |
| 2017-04-30 | $55.42M | 18.39% |
| 2017-01-31 | $46.81M | 7.97% |
| 2016-10-31 | $43.36M | -1.87% |
| 2016-07-31 | $44.19M | 0.39% |
| 2016-04-30 | $44.01M | 22.65% |
| 2016-01-31 | $35.89M | 17.44% |
| 2015-10-31 | $30.56M | 0.20% |
| 2015-07-31 | $30.49M | 2.16% |
| 2015-04-30 | $29.85M | 20.02% |
| 2015-01-31 | $24.87M | 13.76% |
| 2014-10-31 | $21.86M | 4.65% |
| 2014-07-31 | $20.89M | 3.26% |
| 2014-04-30 | $20.23M | 17.89% |
| 2014-01-31 | $17.16M | 12.55% |
| 2013-10-31 | $15.25M | 1.78% |
| 2013-07-31 | $14.98M | 2.45% |
| 2013-04-30 | $14.62M | - |
HealthEquity generated $325.83M in revenue during Q2 2026, up -1.51% compared to the previous quarter, and up 113.30% compared to the same period a year ago.
HealthEquity Revenue Breakdown
HealthEquity Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Jan 25 | Jan 24 | Jan 23 | Jan 22 | Jan 21 |
|---|---|---|---|---|---|
| Service | $478.32M | $455.69M | $430.20M | $426.91M | $430.97M |
| Financial Service, Other | $545.41M | $386.59M | $283.11M | $202.82M | $190.93M |
| Credit and Debit Card | $176.04M | $157.30M | $148.44M | $126.83M | $111.67M |
HealthEquity's latest annual revenue breakdown by segment (product or service), as of Jan 25: Financial Service, Other (45.46%), Service (39.87%), and Credit and Debit Card (14.67%).
Quarterly Revenue by Product
| Product/Service | Jul 25 | Apr 25 | Jan 25 | Oct 24 | Jul 24 | Apr 24 | Jan 24 | Oct 23 | Jul 23 | Apr 23 | Jan 23 | Oct 22 | Jul 22 | Apr 22 | Jan 22 | Oct 21 | Jul 21 | Apr 21 | Jan 21 | Oct 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Service | $117.87M | $119.78M | $124.21M | $119.17M | $116.72M | $118.21M | $118.58M | $107.51M | $105.72M | $105.11M | $114.23M | $108.58M | $103.03M | $104.35M | $112.46M | $102.73M | $109.18M | $102.53M | $111.33M | $104.56M |
| Financial Service, Other | $159.88M | $156.46M | $144.13M | $140.95M | $138.68M | $121.64M | $105.43M | $106.58M | $98.92M | $94.44M | $83.51M | $74.64M | $65.60M | $59.37M | $58.06M | $49.01M | $48.78M | $46.98M | $48.58M | $48.54M |
| Credit and Debit Card | $48.09M | $54.60M | $43.48M | $40.30M | $44.52M | $47.74M | $38.38M | $35.13M | $38.91M | $44.88M | $36.10M | $32.86M | $37.51M | $41.97M | $32.78M | $28.21M | $31.14M | $34.69M | $28.26M | $26.25M |
HealthEquity's latest quarterly revenue breakdown by segment (product or service), as of Jul 25: Financial Service, Other (49.07%), Service (36.18%), and Credit and Debit Card (14.76%).
HealthEquity Revenue Breakdown by Country
Quarterly Revenue by Country
| Country | Jan 23 | Oct 22 | Jul 22 | Apr 22 | Jan 22 | Oct 21 | Jul 21 | Apr 21 | Jan 21 | Oct 20 | Jul 20 | Apr 20 | Jan 20 | Oct 19 | Jul 19 | Apr 19 | Jan 19 | Oct 18 | Jul 18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Credit and Debit Card | $36.10M | $32.86M | $37.51M | $41.97M | $32.78M | $28.21M | $31.14M | $34.69M | $28.26M | $26.25M | $25.32M | $31.84M | $29.69M | $22.53M | $16.73M | $18.29M | $14.54M | $13.89M | $15.42M |
| Service | $114.23M | $108.58M | $103.03M | $104.35M | $112.46M | $102.73M | $109.18M | $102.53M | $111.33M | $104.56M | $103.81M | $111.27M | $122.16M | $87.62M | $26.28M | $26.81M | $25.77M | $25.04M | $24.93M |
| Financial Service, Other | $83.51M | $74.64M | $65.60M | $59.37M | $58.06M | $49.01M | $48.78M | $46.98M | $48.58M | $48.54M | $46.91M | $46.90M | $49.35M | $46.97M | $43.61M | $41.95M | $35.47M | $31.56M | $30.71M |
HealthEquity's latest quarterly revenue breakdown by geography, as of Jan 23: Service (48.85%), Financial Service, Other (35.71%), and Credit and Debit Card (15.44%).
HealthEquity Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| HSIC | Henry Schein | $12.67B | $3.24B |
| GRFS | Grifols | $6.59B | $1.63B |
| JAZZ | Jazz Pharmaceuticals | $4.07B | $1.05B |
| ATR | AptarGroup | $3.58B | $966.01M |
| BIO | Bio-Rad Laboratories | $2.57B | $651.60M |
| GMED | Globus Medical | $2.52B | $598.12M |
| MASI | Masimo | $2.09B | $370.90M |
| HQY | HealthEquity | $1.20B | $325.83M |
| GH | Guardant Health | $739.02M | $232.09M |
| CORT | Corcept Therapeutics | $675.04M | $194.43M |